01 4GlaxoSmithKline Inc.
01 22606282
02 23053202
01 4CABOTEGRAVIR SODIUM
01 4TABLET
01 11938-01-25
02 22026-04-28
03 12038-01-25
Patent Expiration Date : 2026-04-28
Date Granted : 2016-04-26
Brand Name : APRETUDE
Patent Number : 2606282
Filing Date : 2006-04-28
Strength per Unit : 30 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-04-28
Date Granted : 2016-04-26
Patent Expiration Date : 1938-01-25
Date Granted : 2022-10-04
Brand Name : APRETUDE
Patent Number : 3053202
Filing Date : 2018-01-25
Strength per Unit : 30 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 1938-01-25
Date Granted : 2022-10-04
Patent Expiration Date : 2026-04-28
Date Granted : 2016-04-26
Brand Name : VOCABRIA
Patent Number : 2606282
Filing Date : 2006-04-28
Strength per Unit : 30mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-04-28
Date Granted : 2016-04-26
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2038-01-25
Date Granted : 2022-10-04
Brand Name : VOCABRIA
Patent Number : 3053202
Filing Date : 2018-01-25
Strength per Unit : 30mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2038-01-25
Date Granted : 2022-10-04
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
